Chemo-immunotherapy for Older Patients with Chronic Lymphocytic Leukemia – Passé Yet?
Main Authors: | Alexey V. Danilov, John M. Pagel, Jennifer R. Brown, Brian T. Hill |
---|---|
Format: | Article |
Language: | English |
Published: |
Wolters Kluwer
2019-08-01
|
Series: | HemaSphere |
Online Access: | http://journals.lww.com/10.1097/HS9.0000000000000275 |
Similar Items
-
Chemo-immunotherapy for Older Patients with Chronic Lymphocytic Leukemia – Time to Retire?
by: Lydia Scarfò, et al.
Published: (2019-08-01) -
Genetic polymorphisms, chronic lymphocytic leukemia, and the future: are we there yet?
by: Paolo F. Caimi, et al.
Published: (2014-01-01) -
Distinct Activities of Glycolytic Enzymes Identify Chronic Lymphocytic Leukemia Patients with a more Aggressive Course and Resistance to Chemo-Immunotherapy
by: Georg Gdynia, et al.
Published: (2018-06-01) -
T Cell Defects and Immunotherapy in Chronic Lymphocytic Leukemia
by: Elisavet Vlachonikola, et al.
Published: (2021-06-01) -
Current and future treatment strategies in chronic lymphocytic leukemia
by: Krish Patel, et al.
Published: (2021-04-01)